Anaptysbio ANAB
NASDAQ ANAB
$49.32 -0.94 (-1.87%)
As of: Oct 1, 2026 · 10:22 AM EDT

Anaptysbio (ANAB) Other Non-Current Liabilities (2016 - 2026)

Updated

Anaptysbio's Other Non-Current Liabilities was $263.74 million in Q1 2026, down 20.2% from $330.38 million a year earlier and down 4.6% from the prior quarter.

Analysis

Anaptysbio (ANAB) Other Non-Current Liabilities (2016 - 2026) Analysis & Trends

At the end of FY2025, Other Non-Current Liabilities at Anaptysbio came in at $276.53 million, down 21.8% from FY2024.

  • Other Non-Current Liabilities shows a four-year compound annual growth rate of 2.4% (FY2021 to FY2025).
  • In earlier years, Other Non-Current Liabilities was $353.43 million in FY2024 (+13.7%), $310.81 million in FY2023 (+2.1%), $304.41 million in FY2022 (+21.2%) and $251.09 million in FY2021.
  • The Q1 2026 figure marks the lowest quarterly Other Non-Current Liabilities since Q2 2022.
  • Compared with a year earlier, Other Non-Current Liabilities has declined for four straight quarters, with an average decline of 0.8% over the last eight quarters.
  • The best year-over-year quarter for Other Non-Current Liabilities over five years was Q4 2022 (growth of 21.2%); the worst was Q4 2025 (a decline of 21.8%).
  • Per Business Quant data, ANAB's Other Non-Current Liabilities in the three quarters before Q1 2026 was $276.53 million (Q4 2025), $331.84 million (Q3 2025) and $331.36 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Anaptysbio 1.46 Bn 346.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 263.74 Mn
Dec 31, 2025 276.53 Mn
Sep 30, 2025 331.84 Mn
Jun 30, 2025 331.36 Mn
Mar 31, 2025 330.38 Mn
Dec 31, 2024 353.43 Mn
Sep 30, 2024 350.56 Mn
Jun 30, 2024 361.98 Mn
Mar 31, 2024 310.18 Mn
Dec 31, 2023 310.81 Mn
Sep 30, 2023 311.27 Mn
Jun 30, 2023 310.07 Mn
Mar 31, 2023 307.52 Mn
Dec 31, 2022 304.41 Mn
Sep 30, 2022 301.59 Mn
Jun 30, 2022 261.02 Mn
Mar 31, 2022 255.58 Mn
Dec 31, 2021 251.09 Mn
Sep 30, 2020 33,000.00
Jun 30, 2020 180,000.00
API Access

Anaptysbio Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ANAB&period=max&api_key=YOUR_API_KEY